These comprise beta-amyloid (Aβ) plaques in AD, aggregates of α-synuclein in PD and other synucleinopathies, and inclusions of the TAR DNA-binding protein (TDP)-43 in ALS and frontotemporal disorders (FTD) [33]. This evidence concerns the gene TARDBP and frontotemporal dementia.